Trial NCT05703555

View at ClinicalTrials.gov 
Org. Study IDs: INTRUSION
Secondary IDs: 2022-003451-34

Last trial update was posted on 2024-02-28

MeSH Interventions

Maytansine

MeSH Conditions

Stomach Neoplasms

Other Conditions

Metastatic Breast Cancer Metastatic Gastric Cancer Metastatic Lung Cancer

Stopping Reasons

Due to the decision to discontinue the global clinical development program of tusamitamab ravtansine

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID